ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1617

Single Cell Interferon Signatures in Lupus Patient Monocytes Reveal a Differential Impact of Interferon Signaling Between Monocyte Subtypes

Zhongbo Jin1, Mark A. Jensen2, Jessica M. Dorschner1, Danielle Vsetecka1, Shreyasee Amin3, Ashima Makol4, Floranne C. Ernste5, Thomas Osborn6, Kevin G. Moder4, Vaidehi Chowdhary3 and Timothy B. Niewold1, 1Division of Rheumatology and Department of Immunology, Mayo Clinic, Rochester, MN, 2Divsion of Rheumatology and Department of Immunology, Mayo Clinic, Rochester, MN, 3Division of Rheumatology, Mayo Clinic, Rochester, MN, 4Rheumatology, Mayo Clinic, Rochester, MN, 5Division of Rheumatology, Mayo Clinic Rochester, Rochester, MN, 6Dept of Rheumatology, Mayo Clinc, Rochester, MN

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Gene Expression, interferons, monocytes and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus - Human Etiology and Pathogenesis: Autoimmune Disease Transition, Disease Subsets and Prediction of Flares, Cytokines and Autoantibodies

Session Type: Abstract Submissions (ACR)

Background/Purpose Type I interferon (IFN) is a primary pathogenic factor in human systemic lupus erythematosus (SLE).  IFN gene expression signatures have been observed in whole blood and mixed peripheral blood mononuclear cell populations in SLE, but the significance of this IFN signaling in immune cell subsets is still incompletely understood.  We examined gene expression in individual SLE patient monocytes to explore the impact of increased IFN-induced transcription in single cells.

Methods CD14++CD16- classical monocytes and CD14dimCD16+ non classical monocytes from SLE patients were purified by magnetic separation.  The Fluidigm C1 System was used for single cell capture and target gene pre-amplification, and equal numbers of classical and non-classical monocytes were studied.  rtPCR was used to quantify expression of 87 monocyte-related genes, 17 of which were IFN-induced genes.  An individual cell IFN score was generated based upon the expression of the 17 IFN-induced genes.

Results  Monocytes from the same SLE patient blood sample demonstrated varying levels of IFN-induced gene expression.  In classical monocytes, high IFN score correlated with CD32a, IL1B, and IL8 expression.  In non-classical monocytes, high IFN score was correlated with a larger number of inflammatory mediators, including cytokines such as IL12, IL23, and IL15; the immune receptors CD36, CD32a, CD80, and TLR7; and inflammatory signaling genes such as RELA, STAT2, IRAK1, IRAK4, and MyD88. CD16 transcripts were detected in a small group of classical monocytes, despite a lack of surface CD16 expression, suggesting that these cells may be transitioning from classical to non-classical subgroup.  In these cells, CD16 expression was positively correlated with IFN score (p=0.019).

Conclusion This study revealed striking diversity in the IFN responses of individual monocytes, and supports the idea that IFN signaling has distinct effects upon classical and non-classical monocytes, as the IFN signature correlated with a diverse panel of inflammatory mediators in the non-classical subset.  IFN may contribute to the transition from classical to non-classical subtype in SLE.  Single cell studies can reveal effects of IFN on single immune cells and uncommon populations such as non-classical monocytes, which may be masked in whole blood or mixed cell populations.


Disclosure:

Z. Jin,
None;

M. A. Jensen,
None;

J. M. Dorschner,
None;

D. Vsetecka,
None;

S. Amin,
None;

A. Makol,
None;

F. C. Ernste,
None;

T. Osborn,
None;

K. G. Moder,
None;

V. Chowdhary,
None;

T. B. Niewold,

Janssen Pharmaceutica Product, L.P., EMD Serono,

2,

Biogen Idec, EMD Serono,

5.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/single-cell-interferon-signatures-in-lupus-patient-monocytes-reveal-a-differential-impact-of-interferon-signaling-between-monocyte-subtypes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology